Advocacy intelligence hub — real-time data for patient organizations
University of Alabama at Birmingham — PHASE4
Gardiens de Vies
University of California, Los Angeles — PHASE2
London School of Hygiene and Tropical Medicine — PHASE2
St George's, University of London
Institut de Recherche pour le Developpement — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Retrovir
Glaxo Wellcome Inc.
Retrovir
(zidovudine)Orphan drugstandardGlaxo Wellcome Inc.
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
12.1 Mechanism of Action Zidovudine is an antiretroviral agent [see Microbiology ( 12.4 )] .
Pierre Buekens, MD, PhD
Tulane SPHTM
Tanja Taivassalo, Ph.D.
University of Florida, College of Medicine, Department of Physiology and Aging
Jaime Altcheh, Dr
Principal Investigator
Jodie Dionne, MD, LMHC
University of Alabama at Birmingham
📍 EAST NORTHPORT, NY
Elizabeth Partridge, M.D
University of California Davis
📍 SACRAMENTO, CA
Kana Lingambu
Gardiens de Vies